We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

28 hedge funds and large institutions have $45M invested in IDEAYA Biosciences in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

1.15% less ownership

Funds ownership: 54.85%53.7% (-1.2%)

3% less funds holding

Funds holding: 2928 (-1)

46% less capital invested

Capital invested by funds: $83.6M → $45M (-$38.6M)

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
5
Increased
6
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
5VM
1
5AM Venture Management
California
$14.3M
CPX
2
Canaan Partners X
California
$11M
BI
3
BVF Inc
California
$5.29M -$1.07M -151,600 -11%
PA
4
Perceptive Advisors
New York
$4.7M
BC
5
Boxer Capital
California
$3.15M
AI
6
Alphabet Inc
California
$3.1M
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$814K
DCM
8
Driehaus Capital Management
Illinois
$717K
BBA
9
Baker Bros. Advisors
New York
$522K -$520K -73,389 -37%
Vanguard Group
10
Vanguard Group
Pennsylvania
$365K +$76.8K +10,851 +14%
BCM
11
Bridgeway Capital Management
Texas
$350K
Millennium Management
12
Millennium Management
New York
$244K +$146K +20,572 +53%
BlackRock
13
BlackRock
New York
$158K +$190K +26,774 +234%
Goldman Sachs
14
Goldman Sachs
New York
$109K +$46.1K +6,506 +33%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$79K +$46K +6,502 +51%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$71K -$19.9K -2,807 -14%
Squarepoint
17
Squarepoint
New York
$51K -$47.3K -6,685 -35%
Victory Capital Management
18
Victory Capital Management
Texas
$16K +$27.7K +3,916 New
Bank of America
19
Bank of America
North Carolina
$13K +$21.9K +3,096 New
Osaic Holdings
20
Osaic Holdings
Arizona
$4K +$6.02K +850 New
Citigroup
21
Citigroup
New York
$4K +$6.19K +874 +514%
UBS Group
22
UBS Group
Switzerland
$3K +$4.97K +702 New
Morgan Stanley
23
Morgan Stanley
New York
$2K -$2.66K -376 -42%
WEC
24
Winslow Evans & Crocker
Massachusetts
$2K
PAM
25
Panagora Asset Management
Massachusetts
$1K

IDYA Hedge Fund Activity: Q1 2020 in Review

28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2020, worth a combined $45M — down 46% from $83.6M a quarter earlier.

Fund positioning in IDYA was balanced in Q1 2020: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $190K. The largest seller was BVF Inc, cutting an estimated $1.07M.

  • 28 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2020, down from 29 in Q4 2019.
  • Funds reported $45M of IDEAYA Biosciences stock for Q1 2020, down 46% quarter-over-quarter.
  • 5 funds opened new IDEAYA Biosciences positions in Q1 2020 and 5 closed out, a net change of 0 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2020 was BlackRock, an estimated $190K added.
  • The largest IDEAYA Biosciences seller in Q1 2020 was BVF Inc, an estimated $1.07M sold.

Based on aggregated 13F filings for Q1 2020.